TriSalus Life Sciences, Inc. Common Stock
TLSI Real Time Price USDRecent trades of TLSI by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by TLSI's directors and management
Government lobbying spending instances
-
$90,000 Oct 21, 2024 Issue: Medicare/Medicaid
-
$30,000 Jul 22, 2024 Issue: Medicare/Medicaid Health Issues
-
$90,000 Jul 19, 2024 Issue: Medicare/Medicaid
-
$90,000 Apr 21, 2024 Issue: Medicare/Medicaid
-
$90,000 Jan 22, 2024 Issue: Medicare/Medicaid Health Issues
-
$50,000 Jan 20, 2024 Issue: Medicare/Medicaid
-
$50,000 Oct 23, 2023 Issue: Medicare/Medicaid
-
$40,000 Oct 20, 2023 Issue: Medicare/Medicaid Health Issues
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Closed tip dynamic microvalve protection device Nov. 12, 2024
-
Patent Title: Systems and methods for pressure-facilitated therapeutic agent delivery Dec. 26, 2023
-
Patent Title: System and method for selective pressure-controlled therapeutic delivery Aug. 02, 2022
-
Patent Title: Implantable dual pathway therapeutic agent delivery port May. 24, 2022
-
Patent Title: Immunostimulatory sequence oligonucleotides and methods of using the same Apr. 26, 2022
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of TLSI in WallStreetBets Daily Discussion
Recent insights relating to TLSI
Recent picks made for TLSI stock on CNBC
ETFs with the largest estimated holdings in TLSI
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view TLSI Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.